Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06842303

Contribution of New Pancreatic MRI Sequences for the Evaluation of Tumor Response in Pancreatic Adenocarcinomas

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Pancreatic adenocarcinoma is the most pessimistic digestive cancer in terms of prognosis. Tumor response assessment is crucial, and the recent development of new magnetic resonance imaging sequences, such as high resolution applied to diffusion sequences (Harder et al., 2022) or magnetic resonance elastography (MRE) (Steinkohl et al., 2021), could help address this issue.

Conditions

Interventions

TypeNameDescription
DEVICEMagnetic resonance elastography (MRE).Magnetic resonance elastography (MRE) is an imaging technique that measures tissue stiffness by assessing the deformation waves produced under external pressure
DEVICEHigh-resolution diffusion sequence in MRIHigh-resolution diffusion sequence in MRI is an imaging technique that uses the movement of water molecules within tissues to generate detailed images.

Timeline

Start date
2025-06-06
Primary completion
2027-06-06
Completion
2027-06-06
First posted
2025-02-24
Last updated
2025-07-17

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06842303. Inclusion in this directory is not an endorsement.